This PDF is the current document as it appeared on Public Inspection on 09/28/2016 at 08:45 am.
Food and Drug Administration, HHS.
Notice of availability; correction.
The Food and Drug Administration (FDA or Agency) is correcting a notice that appeared in the Federal Register of Tuesday, September 13, 2016 (81 FR 62910). The document announced the availability of a guidance for industry entitled “Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Living Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The document was published with incorrect information of a comment period due date. This document corrects that error.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Jonathan McKnight, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-402-7911.End Further Info End Preamble Start Supplemental Information
In the Federal Register of September 13, 2016, in FR Doc. 2016-21969, on page 62910, the following correction is made:
On page 62910, in the first column under the DATES: caption, the sentence is corrected to read, “Submit either electronic or written comments on Agency guidances at any time.”Start Signature
Dated: September 23, 2016.
Associate Commissioner for Policy.
[FR Doc. 2016-23514 Filed 9-28-16; 8:45 am]
BILLING CODE 4164-01-P